SCHEMBL19157296

SCHEMBL19157296

CCCCN(C)S(=O)(=O)c1cccc(C(=O)Nc2cccc(Cl)c2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 7/20 0.64
▸ PTBP1 P26599 1/20 0.64
▸ CA12 O43570 1/20 0.61
▸ CA1 P00915 1/20 0.61
▸ CA9 Q16790 1/20 0.61
▸ MAPT P10636 6/20 0.60
▸ ALDH1A1 P00352 6/20 0.60
▸ MEN1 O00255 5/20 0.60
▸ KMT2A Q03164 5/20 0.60
▸ HTT P42858 1/20 0.60
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ TSHR P16473 2/20 0.55
▸ RAB9A P51151 5/20 0.54
▸ NPC1 O15118 4/20 0.53
▸ GAA P10253 2/20 0.53
▸ ADORA3 P0DMS8 1/20 0.52
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ ADORA1 P30542 1/20 0.52
▸ SIRT2 Q8IXJ6 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15276915 0.92 LMNA (0.60) LMNAPTBP1CA12CA1CA9
SCHEMBL15276916 0.90 LMNA (0.58) LMNAPTBP1CA12CA1CA9
SCHEMBL18948462 0.89 LMNA (0.69) LMNACA12CA1CA9MAPT
SCHEMBL15276914 0.81 LMNA (0.58) LMNAPTBP1CA12CA1CA9
SCHEMBL15276900 0.81 LMNA (0.67) LMNAPTBP1CA12CA1CA9
SCHEMBL15276896 0.77 LMNA (0.55) LMNAPTBP1MAPTALDH1A1MEN1
SCHEMBL15276891 0.77 LMNA (0.70) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL18947633 0.76 MAPT (0.52) LMNACA12CA1CA9MAPT
SCHEMBL15276793 0.76 SIRT2 (0.54) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL15276892 0.76 MAPT (0.56) LMNAMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
EP-2794565-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2017-07-26 — — EP disclosed
Send feedback